Research Strategy - - New medicines and vaccines currently under development and outcomes studies demonstrating the clinical benefits of our existing product franchises will help propel the Company into major new therapeutic areas and position Merck for a new cycle of growth.
Research pipeline review Aprepitant Depression Emend ™ Prevention of chemotherapy-induced nausea and vomiting Herpes zoster vaccine Herpes zoster (shingles) in adults HIV integrase inhibitor HIV/AIDS HPV vaccine Human papillomavirus (HPV infection can lead to the development of cervical cancer) MK-767 Diabetes and diabetic dyslipidemia Phosphodiesterase-4 inhibitor Asthma and pulmonary...
Aprepitant - [Medication] - Quest Diagnostics Patient Health Library Aprepitant Examples Brand Name Chemical Name Emend aprepitant How It Works Aprepitant prevents and controls nausea and vomiting by blocking the effects of a chemical (P/neurokinin 1 [NK1] receptor antagonist) that is produced in the brain.Aprepitant is not approved for the treatment of chronic nausea or vomiting.Aprepitant interacts with many...
PDF cover 0441.qxd DOLPHIN Current Patents Gazette Patenting in Context News & Highlights from Week 0441 The records appearing in this Gazette will be added to DOLPHIN, the database Of all pharmaceutical inventions in the next week.
author: LEmson
Database E E - investigational drugs, therapies and vaccines # - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z From this page you may order documents with information covering investigational products To purchase documents on-line click on- link attached to selected document!- The fee is $15 per document Documents are delivered by e-mail...
Database A A - investigational drugs, therapies and vaccines # - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z From this page you may order documents with information covering investigational products.
http://www.fda.gov/cder/orange/appendix_a.txt 400, ERYTHROMYCIN ETHYLSUCCINATE E.E.S., ERYTHROMYCIN ETHYLSUCCINATE EC-NAPROSYN, NAPROXEN ECONAZOLE NITRATE, ECONAZOLE NITRATE ECONOCHLOR, CHLORAMPHENICOL ECONOPRED PLUS, PREDNISOLONE ACETATE ECONOPRED, PREDNISOLONE ACETATE EDECRIN, ETHACRYNATE SODIUM EDECRIN, ETHACRYNIC ACID EDETATE DISODIUM, EDETATE DISODIUM EDEX, ALPROSTADIL EDROPHONIUM CHLORIDE PRESERVATIVE FREE, EDROPHONIUM...
Research Strategy - - New medicines and vaccines currently under development and outcomes studies demonstrating the clinical benefits of our existing product franchises will help propel the Company into major new therapeutic areas and position Merck for a new cycle of growth
Research pipeline review Aprepitant Depression Emend ™ Prevention of chemotherapy-induced nausea and vomiting Herpes zoster vaccine Herpes zoster (shingles) in adults HIV integrase inhibitor HIV/AIDS HPV vaccine Human papillomavirus (HPV infection can lead to the development of cervical cancer) MK-767 Diabetes and diabetic dyslipidemia Phosphodiesterase-4 inhibitor Asthma and pulmonary...
NDA Approvals for Calendar Year 2003 NDA APPROVALS FOR CALENDAR YEAR 2003 Updated through December 31, 2003 NDA NUMBER DRUG NAME GENERIC NAME APPLICANT/ SPONSOR CHEMICAL TYPE THERAPEUTIC CLASS APPROVAL DATE - 21434 Xanax XR Alprazolam Pharmacia and Upjohn FR 3 S 17-Jan-03 21305 Sodium Iodide I-131 Sodium Iodide I-131 DraxImage 3,5 S 24-Jan-03 20414 Pyridostigmine Bromide Pyridostigmine Bromide US Army 3 P 05-Feb-03...
author: Susan Daugherty
Drug Approval Package Food and Drug Administration • Center for Drug Evaluation and Research Approval Package Search EMEND (Aprepitant) Capsules Company:--Merck Application No.:--21-549 Approval Date:-3/26/2003 Approval Letter(s) - Printed Labeling - Medical Review(s)- Part 1 - Part 2 - Part 3 - Chemistry Review(s) - Pharmacology Review(s)- Part 1 - Part 2 - Part 3 - Part 4 - Part 5 -...
author: USERNAME
Cancer.gov - Clinical Trial Results Clinical Trial Results Summaries of Recent Cancer Trial Results Virtual Colonoscopy An Effective Screening Alternative for Colorectal Cancer (Posted: 12/08/2003) - In a study of people at average risk for colorectal cancer, a screening technique known as virtual colonoscopy was just as accurate as traditional colonoscopy at detecting potential signs of colon or rectal cancer, and was...
Cancer.gov - Supportive Care Trial Results Supportive Care Trial Results Provides links to clinical trial results about supportive care (care given to improve a patient's quality of life)Aprepitant Improves Results (Posted: 10/28/2003) - Drugs used to treat nausea and vomiting are called anti-emetics
Cancer.gov - Added to Standard Anti-Nausea Medicines, Aprepitant Improves Results On the other hand, he wrote, “decades of research have proven that if an anti-emetic drug prevents cisplatin-induced emesis, it will also block emesis caused by other agents as well.” Ted Trimble, M.D., of the National Cancer Institute’s Cancer Therapy Evaluation Program, agrees that “we still need to determine how best to use [aprepitant] in combination with...
Prescription and Over-the-Counter Drug Product List: 3/2003 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE CAPSULE; ORAL FIORICET W/ CODEINE -D- AB + NOVARTIS 325MG;50MG;40MG;30MG N20232 001 JUL 30, 1992 MAR CAHN -A- AB + WATSON PHARMS 325MG;50MG;40MG;30MG N20232 001 JUL 30, 1992 MAR CAHN ACETAMINOPHEN; CODEINE PHOSPHATE TABLET; ORAL CODRIX -A- + ANDRX PHARMS 500MG;30MG N40441 001...
author: AUTHOR
http://www.merck.com/product/usa/pi_circulars/e/emend/emend_pi.pdf EMEND ® (aprepitant) 9565001 6 Figure 1: Percent of Patients Who Remain Emesis Free Over Time – Cycle 1 02448 72 96120 Hours 0 20 40 60 80 100 Percent of Patients Study 1 Standard Therapy Aprepitant Regimen (N= 260) (N= 261) 024 4872 96120 0 20 40 60 80 100 Study 2 Standard Therapy Aprepitant Regimen (N= 261) (N= 263) p- Value <0
http://www.merck.com/product/usa/pi_circulars/e/emend/emend_pi.pdf page 12
http://www.merck.com/product/usa/pi_circulars/e/emend/emend_pi.pdf page 11
http://www.merck.com/product/usa/pi_circulars/e/emend/emend_pi.pdf page 10
http://www.merck.com/product/usa/pi_circulars/e/emend/emend_pi.pdf page 9
http://www.merck.com/product/usa/pi_circulars/e/emend/emend_pi.pdf page 8
http://www.merck.com/product/usa/pi_circulars/e/emend/emend_pi.pdf page 6
http://www.merck.com/product/usa/pi_circulars/e/emend/emend_pi.pdf page 5
http://www.merck.com/product/usa/pi_circulars/e/emend/emend_pi.pdf page 4
http://www.merck.com/product/usa/pi_circulars/e/emend/emend_pi.pdf page 3
